This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Tuesday's Analysts' Upgrades and Downgrades


American Eagle (AEO) upgraded at Cowen to Outperform. Company posted strong August sales, and should be able to deliver 15% earnings growth.

American Financial Group (AFG) upgraded at Credit Suisse to Outperform from Neutral based on valuation. Cites company has improved profitability and deleveraged its balance sheet. Lowered target price to $33 from $38.

AGCO (AG) upgraded at Credit Suisse to Neutral from Underperform based on margin expansion opportunities and very strong farm cycle. Raised target price to $46 from $17.

Bristol-Myers Squibb (BMY - Get Report) downgraded at Goldman to Sell from Neutral due to valuation. Although management has made attractive moves to lower costs and invest in pipeline, valuation continues to run ahead of fundamentals. Price target at $30.

Dominion Resources (D) downgraded at Bernstein from Outperform to Market Perform. Stock lacks potential catalysts, following the E&P sale and buybacks. $96 price target.

Davita (DVA) upgraded at Deutsche Bank from Hold to Buy. $68 price target. Company should be able to navigate through a Medicare price cut better than previously thought. Company also has the capital to make accretive acquisitions or buy back stock.

Exelis (EXEL) downgraded at Wachovia from Outperform to Market Perform. Late-stage pipeline news is already priced into the stock.

FTI Consulting (FCN) downgraded at Merrill Lynch from Neutral to Sell. Valuation call, as the stock is up 88% for the year.
1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
BMY $72.29 0.04%
DDS $70.91 -2.20%
MAN $77.48 -1.60%
KOP $25.35 -0.24%
KSS $44.59 -2.00%


Chart of I:DJI
DOW 17,750.91 -79.85 -0.45%
S&P 500 2,066.13 -9.68 -0.47%
NASDAQ 4,777.1220 -28.1690 -0.59%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs